[{"Assets_0_FY_USD":325478000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":35831000.0,"NetIncomeLoss_1_FY_USD":4103000.0,"NetIncomeLoss_4_FY_USD":24382000.0,"StockholdersEquity_0_FY_USD":190967000.0,"EarningsPerShareBasic_1_FY_USD":0.1,"EarningsPerShareBasic_4_FY_USD":0.57,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":42571000.0,"Ticker":"VIVO","CIK":"794172","name":"MERIDIAN BIOSCIENCE INC","OfficialName":"Meridian Bioscience Inc. Common Stock","form":"10-K","period":"20190930","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1192599275.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20191126"}]